phentolamine mesylate (ophthalmic)

phentolamine mesylate · Ocuphire Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for phentolamine mesylate (ophthalmic), covering 2022-08-15 to 2022-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis [Phase 2]